Average Co-Inventor Count = 4.98
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance, Inc. (31 from 386 patents)
2. Theravance Biopharma R&d Ip, LLC (12 from 262 patents)
3. Theravance Respiratory Company, LLC (11 from 12 patents)
4. Dice Alpha, Inc. (4 from 4 patents)
5. Advanced Medicine, Inc. (2 from 13 patents)
60 patents:
1. 12421212 - Substituted benzenecarboxamides as IL-17A modulators
2. 12234225 - IL-17 ligands and uses thereof
3. 11718616 - JAK kinase inhibitor compounds for treatment of respiratory disease
4. 11548887 - 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
5. 11447468 - IL-17 ligands and uses thereof
6. 11299492 - JAK kinase inhibitor compounds for treatment of respiratory disease
7. 11274094 - Substituted benzenecarboxamides as IL-17A modulators
8. 10913740 - JAK kinase inhibitor compounds for treatment of respiratory disease
9. 10836744 - Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
10. 10745394 - 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
11. 10590107 - Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
12. 10526330 - JAK kinase inhibitor compounds for treatment of respiratory disease
13. 10377751 - 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
14. 10358433 - Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
15. 10138220 - Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity